Literature DB >> 15147250

Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache.

Roger K Cady1, Curtis P Schreiber, Kathleen U Farmer.   

Abstract

Traditionally, episodic primary headache disorders are characterized by a return of preheadache (normal) neurologic function between episodes of headache. In contrast, patients with chronic headache often do not return to normal neurologic function between headache attacks. This article proposes that the evolution from episodic migraine to chronic headache may parallel the neurologic disruption observed during the progression of an acute migraine attack and that changes in baseline neurologic function between episodes of headache may be a more sensitive indicator of headache transformation than headache frequency alone. Early recognition of nonheadache changes in nervous system function may offer a more sensitive and specific approach to migraine prevention.

Entities:  

Mesh:

Year:  2004        PMID: 15147250     DOI: 10.1111/j.1526-4610.2004.04094.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  12 in total

Review 1.  Mechanism of chronic migraine.

Authors:  Sheena K Aurora; Arun Kulthia; Patricia M Barrodale
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 2.  Cosensitization of pain and psychiatric comorbidity in chronic daily headache.

Authors:  Roger Cady; Kathleen Farmer; J Kent Dexter; Curtis Schreiber
Journal:  Curr Pain Headache Rep       Date:  2005-02

3.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

4.  ID migraine questionnaire in temporomandibular disorders with craniofacial pain: a study by using a multidisciplinary approach.

Authors:  Carlo Di Paolo; Anna Di Nunno; Nicola Vanacore; Gianluca Bruti
Journal:  Neurol Sci       Date:  2009-06-03       Impact factor: 3.307

5.  Advances in drug development for acute migraine.

Authors:  Ryan J Cady; Candace L Shade; Roger K Cady
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

6.  Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology.

Authors:  Srikanth Thalakoti; Vinit V Patil; Srikanth Damodaram; Carrie V Vause; Lauren E Langford; Stacy E Freeman; Paul L Durham
Journal:  Headache       Date:  2007 Jul-Aug       Impact factor: 5.887

7.  A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.

Authors:  Roger Cady; Joel Saper; Kent Dexter; Heather R Manley
Journal:  Headache       Date:  2014-10-23       Impact factor: 5.887

8.  Autonomous control of cardiovascular reactivity in patients with episodic and chronic forms of migraine.

Authors:  Oleg V Mamontov; Laura Babayan; Alexander V Amelin; Rashid Giniatullin; Alexei A Kamshilin
Journal:  J Headache Pain       Date:  2016-05-11       Impact factor: 7.277

Review 9.  Managing migraine by patient profile: role of frovatriptan.

Authors:  Roger K Cady; Kathleen Farmer
Journal:  Patient Prefer Adherence       Date:  2016-04-05       Impact factor: 2.711

10.  Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial.

Authors:  Lu Liu; Luo-Peng Zhao; Claire Shuiqing Zhang; Lin Zeng; Kelun Wang; Jingxia Zhao; Linpeng Wang; Xianghong Jing; Bin Li
Journal:  BMJ Open       Date:  2018-05-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.